NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
02/16/2019
Back to search
Official data from USPTO
Q
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000077271620Class
35, 41, 42, 44, 45
Filing
77271620
Registration
3568317
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
02/16/2019
Trademark type
Combined
Nice classes
35, 41, 42, 44, 45
Filing date
09/05/2007
Registration date
01/27/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/16/2019
Last transaction
02/16/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/01/1982
First use in commerce
02/01/1982
Drawing code
5
Owner type
03
Owner location
PARSIPPANY, NJ, US
Examiner
BEN, LINDSEY HEATHER
Law office
L80
Current location
TMEG LAW OFFICE 108
Holders and representatives
Holders
IQVIA INC.
Quintiles Transnational Corp.
Representatives
ARLENE D. HANKS Moore & Van Allen PLLC
Technical classification
Nice Classes
Class 35Class 41Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Computerized database management and data processing services in the fields of pharmaceuticalpharmacogenomicbiotechnical and medical products and devices; manufacturers' and independent sales representatives in the fields of pharmaceuticalspharmacogenomicbiotechnicalmedical products and devices; marketing services for otherscreating and managing product sales and product launch programs in the fields of pharmaceuticalspharmacogenomicbiotechnicalmedical products and devices; business marketing consulting services in the fields of pharmaceuticalspharmacogenomicbiotechnicalmedical products and devices; market research and analysis services in the fields of pharmaceuticalspharmacogenomicbiotechnicalmedical products and devices; personnel recruitment and placement; providing business informationinformation useful for achieving and maintaining regulatory approval and market introduction of drugsdevices and biologics
Class 41
Educational and training servicesconducting training programsseminarsclassesconferences and workshops in the fields of health carehealth management and disease managementpharmaceutical sales skillspharmaceutical and health productsdistributing course materials in connection therewith
Class 42
Clinical research and testing services in the fields of pharmaceuticalspharmacogenomicbiotechnicalmedical products and devices; product development consultation in the fields of medical products and devices; healthcare policy research and development services; laboratory testing services in the fields of pharmaceuticalpharmacogenomicbiotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managingmonitoring and coordinating clinical studies on human subjects for others
Class 44
Providing healthmedicalpharmaceuticalhealth management and disease management information to others; medical evaluation servicesdeveloping and implementing disease management and treatment protocols and patient outcome analysis services; consulting services in the fields of health caremedical and pharmaceuticals
Class 45
Regulatory research in the pharmaceutical industrybiotechnology industry and the medical and diagnostics industry; consultation services in the field of compliance evaluation to insure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others in the fields of pharmaceuticalpharmacogenomicbiotechnical and medical products and devices; consulting services in the fields of regulatory affairsmanufacturing compliance and validation; providing regulatory information and implementation services relating to the development and validation of drugsdevices and biologics
Publications
History of USPTO decisions and trademark events.
42 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/16/2019
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
02/16/2019
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
02/16/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/16/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
01/17/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/18/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/17/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/01/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/27/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/19/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/12/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/27/2015
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/20/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/08/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/08/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/08/2015
E815
TEAS SECTION 8 & 15 RECEIVED
12/17/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/17/2014
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/22/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
01/27/2009
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/19/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/17/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/26/2008
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/26/2008
IUAF
USE AMENDMENT FILED
11/20/2008
EISU
TEAS STATEMENT OF USE RECEIVED
11/20/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
06/10/2008
PUBO
PUBLISHED FOR OPPOSITION
03/18/2008
NPUB
NOTICE OF PUBLICATION
02/27/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/13/2008
ALIE
ASSIGNED TO LIE
02/13/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/14/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/26/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/26/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/26/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/23/2007
GNRT
NON-FINAL ACTION E-MAILED
10/23/2007
CNRT
NON-FINAL ACTION WRITTEN
10/23/2007
DOCK
ASSIGNED TO EXAMINER
10/17/2007
MPMK
NOTICE OF PSEUDO MARK MAILED
09/11/2007
NWAP
NEW APPLICATION ENTERED
09/10/2007
Continuous trademark protection
Get notified about every new filing that threatens Q or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.